Basic Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Jul 24, 2025; 16(7): 107109
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107109
Figure 3
Figure 3 Thymopoietin mRNA exhibits higher expression in papillary thyroid carcinoma. A: Comparison with normal tissues shows higher thymopoietin (TMPO) mRNA expression in papillary thyroid carcinoma (PTC); B and C: Bias tests reveal no significant publication bias; D: Summary receiver operating characteristic indicates TMPO has discriminative capability in PTC. SMD: Standardized mean difference; SROC: Summary receiver operating characteristic.